Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|September 27, 2014
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaMarc R Mansour, Casie Reed, Amy R Eisenberg, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination TherapyJeremy Worley, Heeju Noh, Daoqi You, et al.
Blood|October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibitionConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Genome Medicine|November 2, 2016
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinomaFilemon S Dela Cruz, Daniel Diolaiti, Andrew T Turk, et al.
Cold Spring Harbor Molecular Case Studies|December 16, 2018
A recurrent novel <i>MGA-NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcomaDaniel Diolaiti, Filemon S Dela Cruz, Gunes Gundem, et al.
Kidney International Reports|March 8, 2022
A Diverse Spectrum of Immune Complex- and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell LymphomaNicole K Andeen, Shahad Abdulameer, Vivek Charu, et al.
Nature Communications|November 27, 2025
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncologyDylan Domenico, Gunes Gundem, Max F Levine, et al.
Cancer Cell|February 16, 2005
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-AblEllen Weisberg, Paul W Manley, Werner Breitenstein, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Pageof 38